Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine population Pharmacokinetics and differences and variation of pharmacokinetics parameters of Imatinib as a tyrosine kinase inhibitor in treatment of chronic my...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Kerman University of Medical Sciences
NCT06859424 · AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), and more
NCT05007873 · Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, and more
NCT00816114 · Chronic Myelogenous Leukemia
NCT03314974 · Acute Leukemia, Acute Myeloid Leukemia, and more
NCT05794880 · Leukemia, Acute Myeloid Leukemia in Remission, and more
Shahid-Bahonar hospital
Kerman, Kerman
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions